Europe Depression Drugs Market Report 2017
- QYR897707
- 124 Pages
- February 2017
- Pharmaceuticals
Sales, means the sales volume of Depression Drugs
Revenue, means the sales value of Depression Drugs
This report studies sales (consumption) of Depression Drugs in Europe market, especially in Germany, France, UK, Russia, Italy, Spain and Benelux, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering
Pfizer
Mylan
APOTEX
PRINSTON INC
TEVA
ROXANE
ZYDUS PHARMS
SUN PHARM
JUBILANT GENERICS
GlaxoSmithKline
Beijing Wansheng
Huahai
Jianfeng
Cadista
Carbosynth Limited
LGM Pharma
Intellipharmaceutics
Market Segment by Countries, this report splits Europe into several key Countries, with sales (consumption), revenue, market share and growth rate of Depression Drugs in these countries, from 2011 to 2021 (forecast), like
Germany
France
UK
Russia
Italy
Spain
Benelux
Split by product type, with sales, revenue, price, market share and growth rate of each type, can be divided into
SSRIs
SNRIs
TCAs
Others
Split by application, this report focuses on sales, market share and growth rate of Depression Drugs in each application, can be divided into
Clinic
Hospital
Europe Depression Drugs Market Report 2017
1 Depression Drugs Overview
1.1 Product Overview and Scope of Depression Drugs
1.2 Classification of Depression Drugs
1.2.1 SSRIs
1.2.2 SNRIs
1.2.3 TCAs
1.2.4 Others
1.3 Application of Depression Drugs
1.3.1 Clinic
1.3.2 Hospital
1.4 Depression Drugs Market by Countries
1.4.1 Germany Status and Prospect (2011-2021)
1.4.2 France Status and Prospect (2011-2021)
1.4.3 UK Status and Prospect (2011-2021)
1.4.4 Russia Status and Prospect (2011-2021)
1.4.5 Italy Status and Prospect (2011-2021)
1.4.6 Spain Status and Prospect (2011-2021)
1.4.7 Benelux Status and Prospect (2011-2021)
1.5 Europe Market Size (Value and Volume) of Depression Drugs (2011-2021)
1.5.1 Europe Depression Drugs Sales and Growth Rate (2011-2021)
1.5.2 Europe Depression Drugs Revenue and Growth Rate (2011-2021)
2 Europe Depression Drugs by Manufacturers, Type and Application
2.1 Europe Depression Drugs Market Competition by Manufacturers
2.1.1 Europe Depression Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.1.2 Europe Depression Drugs Revenue and Share by Manufacturers (2015 and 2016)
2.2 Europe Depression Drugs (Volume and Value) by Type
2.2.1 Europe Depression Drugs Sales and Market Share by Type (2011-2016)
2.2.2 Europe Depression Drugs Revenue and Market Share by Type (2011-2016)
2.3 Europe Depression Drugs (Volume and Value) by Countries
2.3.1 Europe Depression Drugs Sales and Market Share by Countries (2011-2016)
2.3.2 Europe Depression Drugs Revenue and Market Share by Countries (2011-2016)
2.4 Europe Depression Drugs (Volume) by Application
3 Germany Depression Drugs (Volume, Value and Sales Price)
3.1 Germany Depression Drugs Sales and Value (2011-2016)
3.1.1 Germany Depression Drugs Sales and Growth Rate (2011-2016)
3.1.2 Germany Depression Drugs Revenue and Growth Rate (2011-2016)
3.1.3 Germany Depression Drugs Sales Price Trend (2011-2016)
3.2 Germany Depression Drugs Sales and Market Share by Manufacturers
3.3 Germany Depression Drugs Sales and Market Share by Type
3.4 Germany Depression Drugs Sales and Market Share by Application
4 France Depression Drugs (Volume, Value and Sales Price)
4.1 France Depression Drugs Sales and Value (2011-2016)
4.1.1 France Depression Drugs Sales and Growth Rate (2011-2016)
4.1.2 France Depression Drugs Revenue and Growth Rate (2011-2016)
4.1.4 France Depression Drugs Sales Price Trend (2011-2016)
4.2 France Depression Drugs Sales and Market Share by Manufacturers
4.3 France Depression Drugs Sales and Market Share by Type
4.4 France Depression Drugs Sales and Market Share by Application
5 UK Depression Drugs (Volume, Value and Sales Price)
5.1 UK Depression Drugs Sales and Value (2011-2016)
5.1.1 UK Depression Drugs Sales and Growth Rate (2011-2016)
5.1.2 UK Depression Drugs Revenue and Growth Rate (2011-2016)
5.1.5 UK Depression Drugs Sales Price Trend (2011-2016)
5.2 UK Depression Drugs Sales and Market Share by Manufacturers
5.3 UK Depression Drugs Sales and Market Share by Type
5.4 UK Depression Drugs Sales and Market Share by Application
6 Russia Depression Drugs (Volume, Value and Sales Price)
6.1 Russia Depression Drugs Sales and Value (2011-2016)
6.1.1 Russia Depression Drugs Sales and Growth Rate (2011-2016)
6.1.2 Russia Depression Drugs Revenue and Growth Rate (2011-2016)
6.1.6 Russia Depression Drugs Sales Price Trend (2011-2016)
6.2 Russia Depression Drugs Sales and Market Share by Manufacturers
6.3 Russia Depression Drugs Sales and Market Share by Type
6.4 Russia Depression Drugs Sales and Market Share by Application
7 Italy Depression Drugs (Volume, Value and Sales Price)
7.1 Italy Depression Drugs Sales and Value (2011-2016)
7.1.1 Italy Depression Drugs Sales and Growth Rate (2011-2016)
7.1.2 Italy Depression Drugs Revenue and Growth Rate (2011-2016)
7.1.7 Italy Depression Drugs Sales Price Trend (2011-2016)
7.2 Italy Depression Drugs Sales and Market Share by Manufacturers
7.3 Italy Depression Drugs Sales and Market Share by Type
7.4 Italy Depression Drugs Sales and Market Share by Application
8 Spain Depression Drugs (Volume, Value and Sales Price)
8.1 Spain Depression Drugs Sales and Value (2011-2016)
8.1.1 Spain Depression Drugs Sales and Growth Rate (2011-2016)
8.1.2 Spain Depression Drugs Revenue and Growth Rate (2011-2016)
8.1.8 Spain Depression Drugs Sales Price Trend (2011-2016)
8.2 Spain Depression Drugs Sales and Market Share by Manufacturers
8.3 Spain Depression Drugs Sales and Market Share by Type
8.4 Spain Depression Drugs Sales and Market Share by Application
9 Benelux Depression Drugs (Volume, Value and Sales Price)
9.1 Benelux Depression Drugs Sales and Value (2011-2016)
9.1.1 Benelux Depression Drugs Sales and Growth Rate (2011-2016)
9.1.2 Benelux Depression Drugs Revenue and Growth Rate (2011-2016)
9.1.9 Benelux Depression Drugs Sales Price Trend (2011-2016)
9.2 Benelux Depression Drugs Sales and Market Share by Manufacturers
9.3 Benelux Depression Drugs Sales and Market Share by Type
9.4 Benelux Depression Drugs Sales and Market Share by Application
10 Europe Depression Drugs Manufacturers Analysis
10.1 Pfizer
10.1.1 Company Basic Information, Manufacturing Base and Competitors
10.1.2 Depression Drugs Product Type, Application and Specification
10.1.2.1 SSRIs
10.1.2.2 SNRIs
10.1.3 Pfizer Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.1.4 Main BusinessBusiness Overview
10.2 Mylan
10.2.1 Company Basic Information, Manufacturing Base and Competitors
10.2.2 Depression Drugs Product Type, Application and Specification
10.2.2.1 SSRIs
10.2.2.2 SNRIs
10.2.3 Mylan Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.2.4 Main BusinessBusiness Overview
10.3 APOTEX
10.3.1 Company Basic Information, Manufacturing Base and Competitors
10.3.2 Depression Drugs Product Type, Application and Specification
10.3.2.1 SSRIs
10.3.2.2 SNRIs
10.3.3 APOTEX Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.3.4 Main BusinessBusiness Overview
10.4 PRINSTON INC
10.4.1 Company Basic Information, Manufacturing Base and Competitors
10.4.2 Depression Drugs Product Type, Application and Specification
10.4.2.1 SSRIs
10.4.2.2 SNRIs
10.4.3 PRINSTON INC Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.4.4 Main BusinessBusiness Overview
10.5 TEVA
10.5.1 Company Basic Information, Manufacturing Base and Competitors
10.5.2 Depression Drugs Product Type, Application and Specification
10.5.2.1 SSRIs
10.5.2.2 SNRIs
10.5.3 TEVA Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.5.4 Main BusinessBusiness Overview
10.6 ROXANE
10.6.1 Company Basic Information, Manufacturing Base and Competitors
10.6.2 Depression Drugs Product Type, Application and Specification
10.6.2.1 SSRIs
10.6.2.2 SNRIs
10.6.3 ROXANE Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.6.4 Main BusinessBusiness Overview
10.7 ZYDUS PHARMS
10.7.1 Company Basic Information, Manufacturing Base and Competitors
10.7.2 Depression Drugs Product Type, Application and Specification
10.7.2.1 SSRIs
10.7.2.2 SNRIs
10.7.3 ZYDUS PHARMS Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.7.4 Main BusinessBusiness Overview
10.8 SUN PHARM
10.8.1 Company Basic Information, Manufacturing Base and Competitors
10.8.2 Depression Drugs Product Type, Application and Specification
10.8.2.1 SSRIs
10.8.2.2 SNRIs
10.8.3 SUN PHARM Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.8.4 Main BusinessBusiness Overview
10.9 JUBILANT GENERICS
10.9.1 Company Basic Information, Manufacturing Base and Competitors
10.9.2 Depression Drugs Product Type, Application and Specification
10.9.2.1 SSRIs
10.9.2.2 SNRIs
10.9.3 JUBILANT GENERICS Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.9.4 Main BusinessBusiness Overview
10.10 GlaxoSmithKline
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Depression Drugs Product Type, Application and Specification
10.10.2.1 SSRIs
10.10.2.2 SNRIs
10.10.3 GlaxoSmithKline Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
10.10.4 Main BusinessBusiness Overview
10.11 Beijing Wansheng
10.12 Huahai
10.13 Jianfeng
10.14 Cadista
10.15 Carbosynth Limited
10.16 LGM Pharma
10.17 Intellipharmaceutics
11 Depression Drugs Manufacturing Cost Analysis
11.1 Depression Drugs Key Raw Materials Analysis
11.1.1 Key Raw Materials
11.1.2 Price Trend of Key Raw Materials
11.1.3 Key Suppliers of Raw Materials
11.1.4 Market Concentration Rate of Raw Materials
11.2 Proportion of Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Manufacturing Process Analysis of Depression Drugs
12 Industrial Chain, Sourcing Strategy and Downstream Buyers
12.1 Depression Drugs Industrial Chain Analysis
12.2 Upstream Raw Materials Sourcing
12.3 Raw Materials Sources of Depression Drugs Major Manufacturers in 2015
12.4 Downstream Buyers
13 Marketing Strategy Analysis, DistributorsTraders
13.1 Marketing Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Development Trend
13.2 Market Positioning
13.2.1 Pricing Strategy
13.2.2 Brand Strategy
13.2.3 Target Client
13.3 DistributorsTraders List
14 Europe Depression Drugs Market Forecast (2016-2021)
14.1 Germany Depression Drugs Sales Forecast (2016-2021)
14.2 France Depression Drugs Sales Forecast (2016-2021)
14.3 UK Depression Drugs Sales Forecast (2016-2021)
14.4 Russia Depression Drugs Sales Forecast (2016-2021)
14.5 Italy Depression Drugs Sales Forecast (2016-2021)
14.6 Spain Depression Drugs Sales Forecast (2016-2021)
14.7 Benelux Depression Drugs Sales Forecast (2016-2021)
14.8 Europe Depression Drugs Sales Forecast by Type (2016-2021)
14.9 Europe Depression Drugs Sales Forecast by Application (2016-2021)
15 Research Findings and Conclusion
16 Appendix
Methodology
Analyst Introduction
Data Source
Figure Picture of Depression Drugs
Table Classification of Depression Drugs
Figure Europe Sales Market Share of Depression Drugs by Type in 2015
Figure SSRIs Picture
Figure SNRIs Picture
Figure TCAs Picture
Figure Others Picture
Table Application of Depression Drugs
Figure Europe Sales Market Share of Depression Drugs by Application in 2015
Figure Clinic Examples
Figure Hospital Examples
Figure Germany Depression Drugs Revenue and Growth Rate (2011-2021)
Figure France Depression Drugs Revenue and Growth Rate (2011-2021)
Figure UK Depression Drugs Revenue and Growth Rate (2011-2021)
Figure Russia Depression Drugs Revenue and Growth Rate (2011-2021)
Figure Italy Depression Drugs Revenue and Growth Rate (2011-2021)
Figure Spain Depression Drugs Revenue and Growth Rate (2011-2021)
Figure Benelux Depression Drugs Revenue and Growth Rate (2011-2021)
Figure Europe Depression Drugs Sales and Growth Rate (2011-2021)
Figure Europe Depression Drugs Revenue and Growth Rate (2011-2021)
Table Europe Depression Drugs Sales of Key Manufacturers (2015 and 2016)
Table Europe Depression Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Depression Drugs Sales Share by Manufacturers
Figure 2016 Depression Drugs Sales Share by Manufacturers
Table Europe Depression Drugs Revenue by Manufacturers (2015 and 2016)
Table Europe Depression Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Europe Depression Drugs Revenue Share by Manufacturers
Table 2016 Europe Depression Drugs Revenue Share by Manufacturers
Table Europe Depression Drugs Sales and Market Share by Type (2011-2016)
Table Europe Depression Drugs Sales Share by Type (2011-2016)
Figure Sales Market Share of Depression Drugs by Type (2011-2016)
Figure Europe Depression Drugs Sales Growth Rate by Type (2011-2016)
Table Europe Depression Drugs Revenue and Market Share by Type (2011-2016)
Table Europe Depression Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Depression Drugs by Type (2011-2016)
Figure Europe Depression Drugs Revenue Growth Rate by Type (2011-2016)
Table Europe Depression Drugs Sales and Market Share by Countries (2011-2016)
Table Europe Depression Drugs Sales Share by Countries (2011-2016)
Figure Sales Market Share of Depression Drugs by Countries (2011-2016)
Table Europe Depression Drugs Revenue and Market Share by Countries (2011-2016)
Table Europe Depression Drugs Revenue Share by Countries (2011-2016)
Figure Revenue Market Share of Depression Drugs by Countries (2011-2016)
Table Europe Depression Drugs Sales and Market Share by Application (2011-2016)
Table Europe Depression Drugs Sales Share by Application (2011-2016)
Figure Sales Market Share of Depression Drugs by Application (2011-2016)
Figure Germany Depression Drugs Sales and Growth Rate (2011-2016)
Figure Germany Depression Drugs Revenue and Growth Rate (2011-2016)
Figure Germany Depression Drugs Sales Price Trend (2011-2016)
Table Germany Depression Drugs Sales by Manufacturers (2015 and 2016)
Table Germany Depression Drugs Market Share by Manufacturers (2015 and 2016)
Table Germany Depression Drugs Sales by Type (2015 and 2016)
Table Germany Depression Drugs Market Share by Type (2015 and 2016)
Table Germany Depression Drugs Sales by Application (2015 and 2016)
Table Germany Depression Drugs Market Share by Application (2015 and 2016)
Figure France Depression Drugs Sales and Growth Rate (2011-2016)
Figure France Depression Drugs Revenue and Growth Rate (2011-2016)
Figure France Depression Drugs Sales Price Trend (2011-2016)
Table France Depression Drugs Sales by Manufacturers (2015 and 2016)
Table France Depression Drugs Market Share by Manufacturers (2015 and 2016)
Table France Depression Drugs Sales by Type (2015 and 2016)
Table France Depression Drugs Market Share by Type (2015 and 2016)
Table France Depression Drugs Sales by Application (2015 and 2016)
Table France Depression Drugs Market Share by Application (2015 and 2016)
Figure UK Depression Drugs Sales and Growth Rate (2011-2016)
Figure UK Depression Drugs Revenue and Growth Rate (2011-2016)
Figure UK Depression Drugs Sales Price Trend (2011-2016)
Table UK Depression Drugs Sales by Manufacturers (2015 and 2016)
Table UK Depression Drugs Market Share by Manufacturers (2015 and 2016)
Table UK Depression Drugs Sales by Type (2015 and 2016)
Table UK Depression Drugs Market Share by Type (2015 and 2016)
Table UK Depression Drugs Sales by Application (2015 and 2016)
Table UK Depression Drugs Market Share by Application (2015 and 2016)
Figure Russia Depression Drugs Sales and Growth Rate (2011-2016)
Figure Russia Depression Drugs Revenue and Growth Rate (2011-2016)
Figure Russia Depression Drugs Sales Price Trend (2011-2016)
Table Russia Depression Drugs Sales by Manufacturers (2015 and 2016)
Table Russia Depression Drugs Market Share by Manufacturers (2015 and 2016)
Table Russia Depression Drugs Sales by Type (2015 and 2016)
Table Russia Depression Drugs Market Share by Type (2015 and 2016)
Table Russia Depression Drugs Sales by Application (2015 and 2016)
Table Russia Depression Drugs Market Share by Application (2015 and 2016)
Figure Italy Depression Drugs Sales and Growth Rate (2011-2016)
Figure Italy Depression Drugs Revenue and Growth Rate (2011-2016)
Figure Italy Depression Drugs Sales Price Trend (2011-2016)
Table Italy Depression Drugs Sales by Manufacturers (2015 and 2016)
Table Italy Depression Drugs Market Share by Manufacturers (2015 and 2016)
Table Italy Depression Drugs Sales by Type (2015 and 2016)
Table Italy Depression Drugs Market Share by Type (2015 and 2016)
Table Italy Depression Drugs Sales by Application (2015 and 2016)
Table Italy Depression Drugs Market Share by Application (2015 and 2016)
Figure Spain Depression Drugs Sales and Growth Rate (2011-2016)
Figure Spain Depression Drugs Revenue and Growth Rate (2011-2016)
Figure Spain Depression Drugs Sales Price Trend (2011-2016)
Table Spain Depression Drugs Sales by Manufacturers (2015 and 2016)
Table Spain Depression Drugs Market Share by Manufacturers (2015 and 2016)
Table Spain Depression Drugs Sales by Type (2015 and 2016)
Table Spain Depression Drugs Market Share by Type (2015 and 2016)
Table Spain Depression Drugs Sales by Application (2015 and 2016)
Table Spain Depression Drugs Market Share by Application (2015 and 2016)
Figure Benelux Depression Drugs Sales and Growth Rate (2011-2016)
Figure Benelux Depression Drugs Revenue and Growth Rate (2011-2016)
Figure Benelux Depression Drugs Sales Price Trend (2011-2016)
Table Benelux Depression Drugs Sales by Manufacturers (2015 and 2016)
Table Benelux Depression Drugs Market Share by Manufacturers (2015 and 2016)
Table Benelux Depression Drugs Sales by Type (2015 and 2016)
Table Benelux Depression Drugs Market Share by Type (2015 and 2016)
Table Benelux Depression Drugs Sales by Application (2015 and 2016)
Table Benelux Depression Drugs Market Share by Application (2015 and 2016)
Table Depression Drugs Basic Information List
Table Pfizer Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Depression Drugs Sales Market Share (2011-2016)
Table Mylan Basic Information List
Table Mylan Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mylan Depression Drugs Sales Market Share (2011-2016)
Table APOTEX Basic Information List
Table APOTEX Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table APOTEX Depression Drugs Sales Market Share (2011-2016)
Table PRINSTON INC Basic Information List
Table PRINSTON INC Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table PRINSTON INC Depression Drugs Sales Market Share (2011-2016)
Table TEVA Basic Information List
Table TEVA Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table TEVA Depression Drugs Sales Market Share (2011-2016)
Table ROXANE Basic Information List
Table ROXANE Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ROXANE Depression Drugs Sales Market Share (2011-2016)
Table ZYDUS PHARMS Basic Information List
Table ZYDUS PHARMS Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table ZYDUS PHARMS Depression Drugs Sales Market Share (2011-2016)
Table SUN PHARM Basic Information List
Table SUN PHARM Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table SUN PHARM Depression Drugs Sales Market Share (2011-2016)
Table JUBILANT GENERICS Basic Information List
Table JUBILANT GENERICS Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table JUBILANT GENERICS Depression Drugs Sales Market Share (2011-2016)
Table GlaxoSmithKline Basic Information List
Table GlaxoSmithKline Depression Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Depression Drugs Sales Market Share (2011-2016)
Table Beijing Wansheng Basic Information List
Table Huahai Basic Information List
Table Jianfeng Basic Information List
Table Cadista Basic Information List
Table Carbosynth Limited Basic Information List
Table LGM Pharma Basic Information List
Table Intellipharmaceutics Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Depression Drugs
Figure Manufacturing Process Analysis of Depression Drugs
Figure Depression Drugs Industrial Chain Analysis
Table Raw Materials Sources of Depression Drugs Major Manufacturers in 2015
Table Major Buyers of Depression Drugs
Table Distributors/Traders List
Figure Germany Depression Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Germany Depression Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure France Depression Drugs Sales and Growth Rate Forecast (2016-2021)
Figure France Depression Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure UK Depression Drugs Sales and Growth Rate Forecast (2016-2021)
Figure UK Depression Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Russia Depression Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Russia Depression Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Italy Depression Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Italy Depression Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Spain Depression Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Spain Depression Drugs Revenue and Growth Rate Forecast (2016-2021)
Figure Benelux Depression Drugs Sales and Growth Rate Forecast (2016-2021)
Figure Benelux Depression Drugs Revenue and Growth Rate Forecast (2016-2021)
Table Europe Depression Drugs Sales Forecast by Type (2016-2021)
Table Europe Depression Drugs Sales Forecast by Application (2016-2021)
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
